← Back to Search

Faith in Action! Church-based Navigation for Breast Cancer Screening

Los Angeles, CA
N/A
Recruiting
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Korean woman who is 45 years or older
Does not currently have a breast cancer diagnosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a training curriculum to help laypeople in faith-based settings provide breast cancer screening navigation to Korean American women, to see if it increases adherence to breast cancer screening guidelines.

See full description
Who is the study for?
This trial is for Korean women aged 45 or older who are members of participating Korean churches in Los Angeles and haven't had a mammogram in the last two years. They should not currently have breast cancer but must be willing to participate in the study.Check my eligibility
What is being tested?
The 'Faith in Action!' program trains lay health navigators within churches to encourage Korean American women to follow breast cancer screening guidelines. The effectiveness of this culturally adapted curriculum will be compared with a control group through interviews and randomized trials.See study design
What are the potential side effects?
Since this intervention involves education and support rather than medical treatment, there are no direct side effects like those associated with medications or procedures. However, participants may experience emotional or psychological impacts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a Korean woman aged 45 or older.
 show original
Select...
I do not have a current diagnosis of breast cancer.
 show original

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Screening adherence
Secondary study objectives
Breast Cancer Screening Beliefs (Knowledge, Perception, and perceived risk)
Change in Knowledge of Breast Cancer Screening
Participant knowledge, attitudes, and beliefs towards screening (Qualitative)
Other study objectives
Change in NIH PROMIS Global Health

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Faith in Action!Experimental Treatment1 Intervention
A train-the-trainer approach will be used to educate lay health navigators to present the culturally adapted "Faith in Action!" curriculum and to provide breast cancer screening navigation to Korean American women within faith-based settings
Group II: ControlActive Control1 Intervention
A presentation of lifestyle recommendations (e.g., physical activity, nutrition) will be provided to control groups.

Find a Location

Closest Location:Cedars-Sinai Medical Center· Los Angeles, CA· 1982 miles

Who is running the clinical trial?

Cedars-Sinai Medical CenterLead Sponsor
521 Previous Clinical Trials
164,320 Total Patients Enrolled
17 Trials studying Breast Cancer
1,963 Patients Enrolled for Breast Cancer
California Breast Cancer Research ProgramOTHER
15 Previous Clinical Trials
4,182 Total Patients Enrolled
11 Trials studying Breast Cancer
3,734 Patients Enrolled for Breast Cancer

Media Library

Faith in Action! Church-based Navigation Model Clinical Trial Eligibility Overview. Trial Name: NCT05298605 — N/A
Breast Cancer Research Study Groups: Faith in Action!, Control
Breast Cancer Clinical Trial 2023: Faith in Action! Church-based Navigation Model Highlights & Side Effects. Trial Name: NCT05298605 — N/A
Faith in Action! Church-based Navigation Model 2023 Treatment Timeline for Medical Study. Trial Name: NCT05298605 — N/A
~27 spots leftby Jul 2025